Interventional Cardiology Devices Market To Reach USD 26.64 Billion By 2030, Driven By Growing Adoption Of Drug-Eluting Stents

(MENAFN- GetNews) Mordor Intelligence has published a new report on interventional cardiology devices market offering a comprehensive analysis of trends, growth drivers, and future projections.

Introduction

The interventional cardiology devices market generated USD 18.57 billion in 2025 and is forecast to reach USD 26.64 billion by 2030, registering a 7.48% CAGR. The market growth is primarily supported by the increasing prevalence of cardiovascular diseases worldwide, coupled with the growing preference for minimally invasive cardiac procedures that reduce hospital stays and improve recovery outcomes. The expanding base of patients with coronary artery disease, rising healthcare expenditure, and the continuous development of improved devices such as stents, catheters, and imaging systems are also contributing to the interventional cardiology devices market growth across developed and emerging regions.

Hospitals and cardiac centers are increasingly integrating advanced diagnostic and interventional technologies to manage complex heart conditions. The growing adoption of drug-eluting stents, bioresorbable scaffolds, and next-generation balloon catheters has significantly enhanced procedural success rates, making interventional cardiology a preferred treatment pathway for many patients. As a result, the interventional cardiology devices market size continues to expand, supported by favorable reimbursement frameworks and the establishment of specialized cardiac care facilities.

Key Trends Shaping the Interventional Cardiology Devices Market

Rising Burden of Cardiovascular Diseases

The rising incidence of coronary artery disease, heart attacks, and related cardiac conditions remains one of the most significant factors driving the interventional cardiology devices market trends. The global population's aging profile, coupled with unhealthy lifestyle habits such as poor diet, physical inactivity, and tobacco use, has intensified the burden of cardiovascular disorders. These conditions often require interventional treatments using angioplasty balloons, stents, and catheters, fueling consistent demand from hospitals and specialty clinics.

Growing Demand for Minimally Invasive Cardiac Procedures

Minimally invasive procedures have transformed cardiac care by reducing surgical risks, hospitalization time, and patient discomfort. The increasing use of coronary stents and balloon angioplasty in place of open-heart surgeries is creating strong opportunities for device manufacturers. This growing preference has prompted companies to design smaller, flexible, and more efficient devices, enhancing precision during interventions and supporting overall interventional cardiology devices market analysis.

Technological Advancements in Stents and Catheters

Ongoing improvements in the design and materials of interventional devices continue to influence market dynamics. Drug-eluting stents remain widely used for coronary revascularization, while bioresorbable scaffolds and drug-coated balloons are emerging as promising alternatives that minimize long-term complications. The integration of advanced imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) is further aiding real-time assessment and guiding optimal stent placement. These developments are strengthening the interventional cardiology devices market share of leading manufacturers offering diversified and technologically advanced product portfolios.

Favorable Healthcare Infrastructure and Access Expansion

Developing regions across Asia-Pacific, Latin America, and parts of the Middle East are witnessing notable improvements in healthcare infrastructure, with more hospitals incorporating interventional cardiology departments. Government initiatives focusing on early cardiac diagnosis and treatment, coupled with rising healthcare investments, are contributing to improved accessibility to modern cardiac devices. As patient awareness grows, the demand for reliable and cost-effective interventional procedures is anticipated to support long-term interventional cardiology devices market growth.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:

Market Segmentation – Interventional Cardiology Devices Market Analysis

The interventional cardiology devices market is segmented by product type, end user, and geography. Each category plays a crucial role in shaping the market's competitive and operational landscape.

By Product Type

• Coronary Stents

• Bare-metal Stents

• Drug-eluting Stents

• Bio-absorbable Scaffolds

• Catheters

• Angiography Catheters

• IVUS/OCT Catheters

• PTCA Guiding Catheters

• PTCA Balloons

• Guidewires

• Hemostasis & Vascular Closure Devices

• Intravascular Lithotripsy (IVL) Systems

By End-user

• Hospitals

• Ambulatory Surgical Centers

• Cardiac Catheterization Labs

By Material

• Cobalt-Chromium Alloy

• Platinum-Chromium Alloy

• Nitinol

• Polymer/Bio-resorbable

By Geography

• North America

• Europe

• Middle east&Africa

• South America

• Asia pacific

Key Players in the Interventional Cardiology Devices Market

The global interventional cardiology devices market is moderately consolidated, with several international manufacturers competing to expand their portfolios through product launches, partnerships, and regional expansions. Leading companies are focusing on continuous product refinement to meet clinical needs and regulatory standards.

• Cook Medical Inc.

• Abbott Laboratories

• Boston Scientific Corporation

• Terumo Medical Corporation

• Medtronic plc

Conclusion

The interventional cardiology devices market is poised for consistent expansion through the forecast period, supported by the rising global burden of cardiovascular diseases and the increasing acceptance of minimally invasive treatments. With ongoing research focusing on biocompatible materials, imaging precision, and patient-specific device customization, interventional cardiology is set to remain at the forefront of cardiac care advancements.

Market players are expected to prioritize affordability, accessibility, and safety while introducing devices that align with evolving clinical practices and regulatory guidelines. As healthcare systems continue to strengthen their cardiac care infrastructure, opportunities across both developed and emerging regions will broaden further.

Industry Related Reports

Cardiovascular Devices Market: The Global Cardiovascular Devices Market is Segmented by Device Type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices), by Application (Coronary Artery Disease, Arrhythmia and More), by End User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers and More) and Geography.

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

...

MENAFN02012026003238003268ID1110549399